Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00503438 · ClinicalTrials.gov registry record

Ankle Joint Replacement Outcomes Study

A clinical trial of Rheumatoid Arthritis and Osteoarthritis, sponsored by Smith & Nephew.

Completed
Registry status
76
Enrollment target
2
Study locations

NCT00503438 is a study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by Smith & Nephew. The registered enrollment target is 76 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00503438, a study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by Smith & Nephew.

COMPLETED
Registry status
76 participants
Enrollment target
2
Study locations

Study Summary

This post market outcome study will look at the therapeutic results of the Salto Talaris Anatomic ankle prosthesis. The study population will consist of patients who will undergo an ankle arthroplasty procedure with a Salto Talaris ankle implant. An analysis will be conducted of the results, complications and revisions of this prosthesis based on the etiology for which the ankle arthroplasty was performed.

Interventions

  • DEVICE Salto Talaris Ankle

Study Locations (2)

Texas

  • Foot and Ankle Center of South Texas - San Antonio

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2007-10-31
Est. Completion 2023-04-21

Sponsor

Smith & Nephew

72 total trials

What the Registry Record Tells You About NCT00503438

The ClinicalTrials.gov registry entry for NCT00503438 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower). The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Salto Talaris Ankle is the first listed.

NCT00503438 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00503438 about?

NCT00503438 is a clinical study titled "Ankle Joint Replacement Outcomes Study". This post market outcome study will look at the therapeutic results of the Salto Talaris Anatomic ankle prosthesis. The study population will consist of patients who will undergo an ankle arthroplasty procedure with a Salto Talaris ankle implant. An analysis will be conducted of the results, complic...

What is the current status of trial NCT00503438?

This trial is currently completed. The enrollment target is 76 participants. The study started on 2007-10-31. Estimated completion is 2023-04-21.

What conditions does trial NCT00503438 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Post Traumatic Arthritis, Septic Arthritis, Prior Ankle Fusion.

What interventions are being tested in trial NCT00503438?

The interventions under investigation include: Salto Talaris Ankle (DEVICE).

Who is sponsoring clinical trial NCT00503438?

This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00503438 being conducted?

This trial has 2 study locations across Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.